United States Market Research Reports & Industry Analysis

Publications found: 50,761
Sort by:

PHARMASSET - 'IFN-Free Oral Option' for HCV - Not a Virgin Territory Anymore!

US$ 90.00

... ) wave to treat HCV the race to offer the first “IFN free all oral option” seems to have begun. Preliminary data from Abbott’s PhII trial ... ’11 is challenging Pharmasset (VRUS) multiprong approach. For more details, please read our report released on Oct. 24th, 2011 on VRUS titled “IFN-free Oral Option” for ...

October 2011 4 pages

US Medical Imaging Devices Market

US$ 1,000.00

The US has a dominant share in the global medical imaging devices industry. Commercialization of advanced systems, including multi-slice computer tomography (CT), high field magnetic resonance imaging...

October 2011 55 pages

USA Cardiovascular Devices Market Trends and Forecast (2010 - 2015)

US$ 975.00

One in three American adults has some form of Cardiovascular Disease (CVD). Heart disease and stroke are the most common cardiovascular diseases. These are the first and third leading causes of death...

October 2011 72 pages

The US AIDS Diagnostics Market: Test Volumes, Sales Forecasts, and Supplier Shares

US$ 1,480.00

Summary This report presents a detailed analysis of the US AIDS diagnostics market, including test volume and sales forecasts for HIV-1/2, HIV ... , Western Blot and other confirmatory tests performed in the following market segments: Hospitals Commercial/Private Laboratories Blood Banks Physician Offices ...

October 2011 251 pages

Biosimilar/Follow-on Biologics Market Report & Forecast: A Focus on the US (2011-2020)

US$ 1,200.00

With sales worth US$ 57 Million in 2010, biosimilars are still far from their billion dollar sales potential that most analysts believe they will generate. This market, however, unlike small molecule...

October 2011 152 pages

Gastrointestinal (GI) Endoscopy Devices: Market Research Report

US$ 4,500.00

This report analyzes the US market for Gastrointestinal (GI) Endoscopy Devices in US$ Million by the following Product Segments: GI Videoscopes (Video Colonoscopes, Video Gastroscopes, Video Duodenoscopes, Video Ultrasound Endoscopes, & Others (Includes Video Sigmoidoscope & Video Enteroscope)), Endoscopic ...

October 2011 284 pages

Meeting Expectations with Steady Growth- Trend to Continue

US$ 90.00

... need along with approved indication… For more details, please read our report released on October 21, 2011 on Alexion (ALXN), titled “Meeting Expectations with Steady Growth- Trend ...

October 2011 5 pages

2012 U.S. Radio TV Broadcast Equipment Report

US$ 149.00

The Radio TV Broadcast Equipment report, published annually by Barnes Reports, contains timely and accurate industry statistics, forecasts and demographics. The report features 2012 current and 2013 f...

October 2011 171 pages

Opportunities in the US Aerospace and MRO market: 2011-2016, October 2011

US$ 3,400.00

... features of “Opportunities in US Aerospace and MRO Market 2011 - 2016” include these: Market size estimates in terms of dollar value and number of units delivered in various ... (2005– –2010) and forecast (2011–2016) for US aerospace MRO market Growth opportunities in US aerospace industry Benefits of Lucintel Report: Lucintel’s core competency is in market ...

October 2011 86 pages

US Wine Market Outlook 2014

US$ 900.00

The US wine industry has been growing at a fast pace over the past few years, and has established a niche place in the global market. With a total contribution of 7.5% in global wine production, the U...

September 2011 75 pages

US Food Processing Machinery Market

US$ 1,000.00

Manufacturers of food processing machineries are facing a rapidly changing and highly demanding competitive environment. The food, beverage, pharmaceuticals, and personal care industries that purchase...

September 2011 45 pages

State of the Industry: Asian Restaurants in the U.S.

US$ 129.00

Note: Formats of Delivery: Word and ExcelPDF upon request State of the Industry reports are concise, yet detailed studies filled with priceless data, forecasts, and objective analysis. The amount of...

September 2011 -

The US Orthopedics Market: Strategic Assessments of Leading Suppliers

US$ 7,600.00

The report provides a strategic overview of the US orthopedics market, including forecasts for major market segments and product categories. In addition, the report presents a concise review of the major trends with potentially significant impact on the US ...

September 2011 620 pages

Vertex - Near Term Positive Long Term Neutral

US$ 140.00

... therapy area is heating up, Vertex (VRTX) will continue to have the edge for at least 3yrs. We expect most of the near term milestones related for ... read our report released on 23th September, 2011 on VRTX titled “Near Term Positive Long Term Neutral”.

September 2011 5 pages

Therapeutic Apheresis: Market Research Report

US$ 4,500.00

This report analyzes the US market for Therapeutic Apheresis in US$ Thousand by the following procedures: Photopheresis, Plasmapheresis, Erythrocytapheresis, Plateletpheresis, Leukapheresis, and Lipidpheresis. The specific end-use segments analyzed are Neurology Disorders, Hematology & Oncology Disorders, ...

September 2011 126 pages

Direct-To-Consumer (DTC) Advertising in Pharmaceuticals: Market Research Report

US$ 4,200.00

This report analyzes the US market for Direct-To-Consumer (DTC) Advertising in Pharmaceuticals in US$ Million by the following media channels - Internet Advertising, Print Media, Television, and Others (include Outdoor and Radio Advertising). Annual estimates and forecasts are provided for the period 2009 ...

September 2011 577 pages

Pharmasset - Tapping Both IFN and IFN-Free Opportunities

US$ 140.00

... daily NS5A inhibitor (BMS-790052) +Peg-IFN/RBV. Efficacy data of BMS-790052 raises ... NS5A inhibitor) - Once daily w/o IFN. PSI-7977+ Peg-IFN/RBV have shown advantage over the ... IFN-free combinations. For more details, please read our report released on 21th September, 2011 on VRUS titled “Tapping Both IFN and IFN ...

September 2011 7 pages

ALEXION - Great Expectations From Label Expansion

US$ 140.00

We have a positive expectation for the approval of Eculizumab (L, Soliris, Paroxysmal Nocturnal Hemoglobinuria) in Atypical ... more details, please read our report released on September 16, 2011 on Alexion (ALXN), titled “Great Expectations From Label Expansion”.

September 2011 4 pages

ARQULE - Read-Out Only in 2013

US$ 140.00

... . It is an attractive acquisition target due to…. For more details, please read our report released on 13th September, 2011 on ARQL titled “Read-Out Only in 2013”.

September 2011 4 pages

PHARMASSET - Another Step Towards Success!

US$ 90.00

Pharmasset (VRUS) announced top line data of PSI-7977 PhIIb, PROTON ... read our report released on 13th September, 2011 on VRUS titled “Another Step Towards Success”.

September 2011 4 pages

ARDEA - Entering the Pivotal Phase

US$ 140.00

After a long wait, Ardea (RDEA) reached an agreement with the FDA on the proposed PhIII ... in the report released on 12th September, 2011 on RDEA titled “Entering the Pivotal Phase”. For more details please ask for our initiation ...

September 2011 3 pages

ONYX PHARMA - Testing Time Ahead in the Hematological Cancer Space

US$ 140.00

... read our report released on 2nd September, 2011 on ONXX titled “Testing Time Ahead in the Hematological Cancer Space”.

September 2011 3 pages

State of the Industry:  Book Stores in the U.S.

US$ 129.00

Note: Formats of Delivery: Word and ExcelPDF upon request State of the Industry reports are concise, yet detailed studies filled with priceless data, forecasts, and objective analysis. The amount of...

August 2011 -

Gilead - Complera Approval - Positive Long Term Impact

US$ 90.00

Approval of Complera (GILD’s Truvada + Tibotec’s Edurant) reiterates GILD’s ... HIV infection. With the current economic turmoil, approval of once-daily Complera (formerly Fixed Dose Combination drug) impact may ... report released on 12th August, 2011, titled – “Complera Approval - Positive Long Term Impact”

August 2011 5 pages

Celgene - Global Share Gains Continue + Pipeline Potential

US$ 140.00

... all commercial metrics – global share and duration gains, continued expansion of market ... access through approvals and reimbursements in the US and international market, and noteworthy operating efficiency places Celgene ... – “Global Share Gains Continue + Pipeline Potential”.

August 2011 6 pages

Biogen Idec - Delivering Beyond Expectations – On the Strength of Innovative Products

US$ 140.00

... , increase in revenue base, and pipeline success – all have contributed to Biogen’s (BIIB) outstanding performance. Marketed products would sustain the growth ... read our report released on 29th July, 2011 on BIIB titled “Delivering Beyond Expectations – On the Strength of Innovative Products”.

July 2011 6 pages

Pharmasset - Poised to Deliver the Best Oral Option Against HCV Infection

US$ 140.00

Pharmasset (VRUS) has created immense value for its shareholders by promising ... more detail, please read our note released on 28th July on Pharmasset titled “Poised to Deliver the Best Oral Option Against HCV Infection”.

July 2011 5 pages

ALEXION - Geography + Label Expansion = Long Term Growth

US$ 140.00

... , we have analyzed Alexion (ALXN) future prospects. Full details are highlighted in the report, released on July 26, 2011, titled “Geography + Label Expansion = Long Term ...

July 2011 4 pages

US Analytical Instruments Market Forecast

US$ 1,000.00

Single User PDF Format: US$ 1,000.00 Multi-User License: US$ 1,500.00 Hard Copy: US$ 1,100.00 CD-ROM: US$ 1,100.00 The world has witnessed a strong pattern of demand for analytical instruments and au...

July 2011 70 pages

US e-health Market Analysis

US$ 1,000.00

Single User PDF Format: US$ 1,000.00 Multi-User License: US$ 1,500.00 Hard Copy: US$ 1,100.00 CD-ROM: US$ 1,100.00 The US represents one of the most developed healthcare markets global...

July 2011 75 pages

Americas Monthly LNG Trade & Price Database, 2010

US$ 3,500.00

Price: Hard Copy - US$ 3,750.00 Price: CD-ROM - US$ 3,750.00 Price: Electronic (e.g. PDF) - US$ 3,500.00 Price: Site Licence - US$ 7,000.00 Price: Enterprisewide - US$ 10,500.00 “Americas Monthly LNG...

July 2011 -

Regeneron - Entering the Commercial TRAP

US$ 140.00

... US next month (PDUFA: August, 20). What are the risks to its commercial success and future of REGN’s pipeline? A comprehensive analysis about the ...

July 2011 7 pages

A Big BiTE - ALL Next!

US$ 140.00

... ) are favorable and increases our confidence in the potential of MITI’s BiTE (Bispecific T-Cell Engager) technology platform for developing better therapeutic ... please read our note released on 12th July on MITI titled “A Big BiTE - ALL Next”. With this purchase please inquire the discount on our ...

July 2011 5 pages

Mixed CARE-MS I data – Good for BIIB!

US$ 90.00

... (EDSS) was not achieved (vs. reduction of 91% in PhII data at 36 months) in its pivotal PhIII trial – CARE-MS I. What does this bode for other players ... ? Please read our report, released on 11th July, 2011, titled – “Mixed CARE-MS I data – Good for BIIB!”

July 2011 4 pages

Niche Products, Label expansion and No Competition - Growth Drivers

US$ 140.00

... details are highlighted in the report, released on July 5, 2011, titled “Niche Products, Label expansion and No Competition – Growth Drivers”. With this report, you will ...

July 2011 7 pages

AMGEN, Outperform, GILEAD, Outperform - Gilead and Amgen - Offer Long Term Value

US$ 140.00

Our relative valuation reiterates GILEAD (GILD) and AMGEN (AMGN) as value buys. While GILD is trading at lowest PE’11, P/C, AMGN trades ... , please read our report, released on 29th June, 2011 titled, “Gilead and Amgen - Offer Long Term Value”.

June 2011 10 pages

BIOGEN IDEC - Oral MS Landscape/ Additive news flow - Getting Better for BIIB

US$ 140.00

We reiterate our Outperform rating on Biogen Idec (BIIB) with a TP of $108 (WACC 8%) in light of recent news flow that ... read our report released on 24th June, 2011 on BIIB titled “Oral MS Landscape/ Additive news flow – Getting Better for BIIB”.

June 2011 2 pages

Eliquis (Apixaban) meets endpoints in ARISTOTLE - Stock Price Reaction premature

US$ 140.00

... from the ARISTOTLE trial, Eliquis met both, the primary (reduction in stroke and embolism) and secondary endpoint (reduction in major bleeding and ... stock price reaction is a bit premature, as detailed data is crucial to understand Eliquis relative efficacy/safety compared to Pradaxa and Xarelto. From a trial ...

June 2011 3 pages

REGENERON, Outperform - Is Trap Safer? Rilonacept vs. NVS’ Ilaris in Gout

US$ 90.00

... ) or colchicine primarily on safety concerns. Based on our analysis, we reiterate our Outperform rating on Regeneron (REGN) with a revised TP of $62 (vs. previous $65) as we believe both these drugs ... read our report released on 23rd June, 2011 on REGN named “Is Trap Safer? Rilonacept vs. NVS’ Ilaris in Gout”.

June 2011 5 pages

U.S. Convenience Stores Market Outlook to 2013

US$ 800.00

Single User PDF Format: US$ 800.00 Multi-User License: US$ 1,500.00 Hard Copy: US$ 900.00 CD-ROM: US$ 900.00The US convenience stores (c-stores) industry is one of the world’s largest and fastest gro...

June 2011 65 pages

US Retirement Income Market Analysis

US$ 800.00

Single User PDF Format: US$ 800.00 Multi-User License: US$ 1,400.00 Hard Copy: US$ 900.00 CD-ROM: US$ 900.00 Despite the global economic financial turmoil, the US retirement market picked up strong p...

June 2011 50 pages

US Fast Food Market Forecast to 2014

US$ 800.00

Single User PDF Format: US$ 800.00 Multi-User License: US$ 1,200.00 Hard Copy: US$ 900.00 CD-ROM: US$ 900.00 Globally, US maintained its position as one of the leading fast food nations even during t...

June 2011 60 pages

US Cosmetic & Toiletries Market Analysis

US$ 1,000.00

Single User PDF Format: US$ 1,000.00 Multi-User License: US$ 1,500.00 Hard Copy: US$ 1,100.00 CD-ROM: US$ 1,100.00 Cosmetics & Toiletries market in the US witnessed healthy recovery in the year 2...

June 2011 95 pages

Investing in the US Real Estate Sector

US$ 300.00

... predictions of escalating rental rates. Aruvian's R'search’s focus report on Investing in the US Real Estate Industry is the ideal guide to have an overview of the ... real estate industry. The report covers all the major markets, that is, the office market, retail, industrial, and investment. An ...

June 2011 100 pages

Analyzing Renewable Portfolio Standards in the US

US$ 300.00

... energy sources. Aruvian's R'search presents an analysis of the Renewable Portfolio Standards in the United States in its research report Analyzing Renewable Portfolio Standards in the US. The report talks about the importance ...

June 2011 125 pages

Analyzing the US Financial Services Industry

US$ 300.00

... equities, foreign exchange and derivatives. Historical data from the United States shows surprisingly large variations in the economic importance of finance ... report from Aruvian's R'search – Analyzing the US Financial Services Industry – takes a look at the US financial services industry and the upheavals it is ...

June 2011 315 pages

Analyzing Combined Heat and Power in the US

US$ 300.00

... a research report that looks at the potential of CHP in the United States in its report Analyzing Combined Heat and Power in the US. The report takes a look at the basic ...

June 2011 85 pages

Analyzing Fixed Line Telecommunication Industry in the US

US$ 250.00

... an analysis of the fixed line telecommunication industry in the US. The report begins with an analysis of the basics of the telecommunication industry and then moves on to analyze the industry ...

June 2011 60 pages

Analyzing the US Utility Energy Storage Market

US$ 325.00

... technologies for addressing utility storage applications. Aruvian's R'search analyzes the market for utility energy storage technologies in its research report Analyzing the US Utility Energy Storage Market ...

June 2011 110 pages

Framework Analyses of the US Energy & Renewable Energy Industry

US$ 200.00

The United States is a leader in the field of renewable energy industry. ... US renewable energy and energy industry in a series of frameworks such as the SWOT analysis, PEST analysis, and Michael ... : Porter's Five Forces Strategy Analysis These framework analyses help the reader understand and grasp the strategic ...

June 2011 90 pages

Filters

Search

Categories

3,301
2,115
1,731
1,559
1,352
998
877
715
688
664
648
647
491
451
433
390
369
331
318
294
272
268
249
237
229
202
200
169
129
121
71
64
61
60
58
51
36
34
33
31
26
25
23
23
21
21
21
19
19
16
14
14
14
13
12
12
10
9
9
9
8
8
7
7
7
6
6
6
5
5
5
5
5
5
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
3
1
1
1
5
1
1
1
1
2
1
1
1
1
1
1
3
1
1
1
1
2
1
4
1
1
1
1
3
2
1
1
1
23
1
1
1
1
1
1
1
1,369
165
158
131
127
79
67
48
46
43
38
36
30
28
27
25
22
19
17
16
15
14
13
13
11
10
10
10
7
7
6
5
5
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
3
1
9
3
1
1
38
1
1
12
5
1
1
1
5
1
12
2
1
2
1
4
1
1
2
1
1
1
48
6
125
64
55
53
35
33
32
29
25
21
20
15
13
12
12
12
11
11
10
9
9
8
8
7
7
6
4
3
3
3
2
2
2
2
2
1
1
1
1
2
1
1
1
1
1
81
3
1
1
8
1
1
2
1
1
1
2
3
2
1
3
2
1
1
10
68
35
9
5
5
2
14
1
61
1
11
42
43
932
141
13
3
1
29
1
25
3
1
4
99
5
2
1
7,736
6
35
30
33
22
6
4
6
26
169
7
14
11
7
42
34
7
62
4
23
22
19
7
2
1
13
5
1
42
4
2
8
1
69
6
17
1
26
6
7
2
1
3
3
1
6
2
5
16
14
6
6
360
10
2
2
2
308
4
10
8
1
17
13
15
1
6
5
14
54
1,034
17
1
1
2
40
14
10
1
20
6
66
40
31
18
3
4
34
1
3
69
5
25
17
6
2
9
2
107
87
40
20
6
5
7
2
68
4
82
4
5
2
5
19
70
313
75
23
6
21
80
4
41
40
19
3
3
138
6
36
34
14
6
4
198
198
80
5
4
9,779
4
537
611
19
144

Publishers

10,780
9,634
1,509
91
64
58
39
38
6
1
259
1
10
7
4,602
3
27
1
1
10
7,395
2
5
93
3,564
52
350
2
1
3
41
1
43
112
1
1
5
1
2
1
1
11
4,997
1
441
132
20
2
2
6
2
51
2,465
437
418
2
8
3
2
6
2
15
399
27
4
11
22
158
1,610
1
15
186
5
19
10
160
109
49
1
10
73
47
1
1

Regions

50,761

Price

Date

Pages

Offers

2
1